Arndt Schottelius Founder of Maxion Therapeutics Backed byBusiness Growth FundChristopher OldsLucy Edwardes Jones LinkedIn SourcesMaxion Therapeutics: £58 Million (Series A) Closed For Developing KnotBody Drugs For Ion Channel- And GPCR-Driven Diseases — 2025-03 Browse all founders · Browse investors
